IBD Disability Index Is Associated With Both Direct and Indirect Costs of Inflammatory Bowel Disease

被引:5
|
作者
Shafer, Leigh Anne [1 ,2 ]
Shaffer, Seth [1 ,2 ]
Witt, Julia [2 ,3 ]
Nugent, Zoann [2 ,4 ]
Bernstein, Charles N. [1 ,2 ]
机构
[1] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Internal Med, Winnipeg, MB, Canada
[2] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada
[3] Univ Manitoba, Fac Arts, Dept Econ, Winnipeg, MB, Canada
[4] Cancercare Manitoba, Winnipeg, MB, Canada
关键词
absenteeism; direct costs; disability; indirect costs; presenteeism; QUALITY-OF-LIFE; CROHNS-DISEASE; ULCERATIVE-COLITIS; MANAGEMENT; PRESENTEEISM; EMPLOYMENT; FATIGUE; COHORT; WORK;
D O I
10.1093/ibd/izab248
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: We aimed to determine both direct (medical) and indirect (lost wages) costs of IBD and the association between the degree of IBD-related disability and extent of IBD-related costs. Methods: Persons age 18-65 from the population-based University of Manitoba IBD Research Registry completed a survey including the IBD Disability Index (IBDDI) and questions related to employment, missed work (absenteeism), and reduced productivity at work (presenteeism). Administrative health data including surgeries, hospitalizations, physician claims, and prescriptions were linked to the survey and assessed. To calculate annual wage loss, number of days of missed work was multiplied by the average wage in Manitoba for the given occupation per Statistics Canada. Costs were adjusted to 2016-17 Canadian dollars. Using descriptive and regression analysis, we explored the association between IBDDI and annual direct and indirect costs associated with IBD. Results: Average annual medical costs rose from $1918 among those with IBDDI 0-4 to $9,993 among those with IBDDI 80-86. Average annual cost of lost work rose from $0 among those with IBDDI 0-4 to $30,101 among those with IBDDI 80-86. Using linear regression, each additional unit of IBDDI was associated with an increase of $77 in annual medical cost (95% CI, $52-102; P < .001) and an increase of $341 in annual cost of lost wages (95% CI, $288-395; P < .001). Conclusions: Costs related to IBD are significantly associated with the degree of IBD-related disability. Among the approximate 30% of the IBD population with IBDDI scores >= 40, the indirect costs of absenteeism and presenteeism accounts for similar to 75% of the total IBD-related costs.
引用
收藏
页码:1189 / 1197
页数:9
相关论文
共 50 条
  • [31] THE SIDEROPHORE YERSINIABACTIN POTENTIATES INFLAMMATORY BOWEL DISEASE (IBD)-ASSOCIATED FIBROSIS
    Lopez, Lacey R.
    Moore, Lyndsey
    Broberg, Christopher A.
    Tibbs, Taylor N.
    Rothemich, Aaron
    Arthur, Janelle C.
    GASTROENTEROLOGY, 2019, 156 (06) : S1149 - S1149
  • [32] Gut associated bacterial microflora in patients with inflammatory bowel disease (IBD)
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 40 (05): : 663 - 663
  • [33] Factors Associated With Hospital Readmissions in Patients With Inflammatory Bowel Disease (IBD)
    Blonski, Wojciech
    Synnestvedt, Marie B.
    Tierney, Ann
    Marchioni, Renee M.
    Buchner, Anna
    Lichtenstein, Gary R.
    GASTROENTEROLOGY, 2012, 142 (05) : S788 - S788
  • [34] Toxicity associated with the use of cyclosporin in patients with inflammatory bowel disease (IBD).
    Sternthal, M
    George, J
    Kornbluth, A
    Lichtiger, S
    Present, D
    GASTROENTEROLOGY, 1996, 110 (04) : A1019 - A1019
  • [35] Ipilimumab associated colitis: a modern mimic of Inflammatory Bowel Disease (IBD)
    Tripathi, M.
    Fryer, E.
    Williamson, K. D.
    Karydis, I.
    Gupta, A.
    Keshav, S.
    Middleton, M.
    VIRCHOWS ARCHIV, 2014, 465 : S235 - S236
  • [36] Disability in Inflammatory Bowel Disease
    Abraham, Bincy P.
    Sellin, Joseph H.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (02) : 429 - +
  • [37] Estimating the direct and indirect costs associated with Parkinson's disease
    Rodriguez-Blazquez, Carmen
    Joao Forjaz, Maria
    Lizan, Luis
    Paz, Silvia
    Martinez-Martin, Pablo
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 889 - 911
  • [38] Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease
    Choi, Hyun Ho
    Cho, Young-Seok
    GUT AND LIVER, 2017, 11 (03) : 319 - 320
  • [39] VALIDATON OF THE INFLAMMATORY BOWEL DISEASE DISABILITY INDEX FOR SELF-REPORT
    Paulides, Emma
    Kim, Catherine
    Frampton, Chris
    Gearry, Richard B.
    Eglinton, Tim
    Leong, Rupert W.
    Mulder, Chris J.
    McCombie, Andrew
    GASTROENTEROLOGY, 2018, 154 (06) : S996 - S996
  • [40] Validation of the Inflammatory Bowel Disease Disability Index for self-report
    Paulides, E.
    Kim, C.
    Frampton, C.
    Gearry, R. B.
    Eglinton, T.
    Leong, R. W.
    De Boer, N. K. H.
    Mulder, C. J. J.
    Mccombie, A. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 98 - 98